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Evaluation of Coronary Artery Stenosis in Individuals
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Objectives The purpose of this study was to evaluate the diagnostic accuracy of electrocardiographically gated 64-multidetector
row coronary computed tomographic angiography (CCTA) in individuals without known coronary artery disease (CAD).
Background CCTA is a promising method for detection and exclusion of obstructive coronary artery stenosis. To date, no pro-
spective multicenter trial has evaluated the diagnostic accuracy of 64-multidetector row CCTA in populations
with intermediate prevalence of CAD.
Methods We prospectively evaluated subjects with chest pain at 16 sites who were clinically referred for invasive coronary
angiography (ICA). CCTAs were scored by consensus of 3 independent blinded readers. The ICAs were evaluated
for coronary stenosis based on quantitative coronary angiography (QCA). No subjects were excluded for baseline
coronary artery calcium score or body mass index.
Results A total of 230 subjects underwent both CCTA and ICA (59.1% male; mean age: 57  10 years). On a patient-
based model, the sensitivity, specificity, and positive and negative predictive values to detect 50% or 70%
stenosis were 95%, 83%, 64%, and 99%, respectively, and 94%, 83%, 48%, 99%, respectively. No differences in
sensitivity and specificity were noted for nonobese compared with obese subjects or for heart rates 65 beats/
min compared with 65 beats/min, whereas calcium scores 400 reduced specificity significantly.
Conclusions In this prospective multicenter trial of chest pain patients without known CAD, 64-multidetector row CCTA pos-
sesses high diagnostic accuracy for detection of obstructive coronary stenosis at both thresholds of 50% and
70% stenosis. Importantly, the 99% negative predictive value at the patient and vessel level establishes CCTA as an
effective noninvasive alternative to ICA to rule out obstructive coronary artery stenosis. (A Study of Computed Tomog-
raphy [CT] for Evaluation of Coronary Artery Blockages in Typical or Atypical Chest Pain; NCT00348569) (J Am Coll
Cardiol 2008;52:1724–32) © 2008 by the American College of Cardiology Foundation
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November 18, 2008:1724–32 The ACCURACY Trial of 64-MDCToronary computed tomographic angiography (CCTA) has
merged as a promising noninvasive method for the detection
nd exclusion of obstructive coronary artery disease (CAD) (1).
owever, widespread clinical applicability of CCTA remains
imited, because earlier studies have excluded subjects based on
aseline coronary artery calcium (CAC) score or heart rate and
ave assessed diagnostic performance of CCTA after exclusion
f nonevaluable coronary artery segments. In addition, these
tudies were largely performed in patients with high prevalence
high clinical pre-test likelihood), which can potentially skew
he results when applied to other pre-test likelihood
roups. Recent studies evaluating the diagnostic perfor-
ance of newer 64-multidetector (row) computed to-
ography (MDCT) scanners have shown further poten-
ial for an improvement in CCTA diagnostic accuracy
nd reduction in the number of nonevaluable coronary
rtery segments compared with older-generation CT
canners (2). However, these studies have been limited to
ingle centers for patients with primarily high prevalence
f obstructive coronary artery stenoses. To our knowl-
dge, to date, no prospective multicenter trial for CCTA
fficacy in patients without known CAD or with inter-
ediate prevalence of CAD has yet been reported.
See page 1733
The aim of the present prospective blinded multicenter
tudy was to test the ability of current-generation 64-
ultidetector row CCTA to detect or exclude significant
oronary artery stenosis in chest pain subjects without
nown CAD, using an American Heart Association (AHA)
lassification of coronary artery segments (3). We assessed
he diagnostic performance of 64-multidetector row CCTA
n a per-patient and -vessel basis, including all patients and
ll vessels for final efficacy analysis.
ethods
atients. The ACCURACY (Assessment by Coronary
omputed Tomographic Angiography of Individuals Un-
ergoing Invasive Coronary Angiography) study was de-
igned to prospectively evaluate adult subjects with chest
ain who were being clinically referred for nonemergent
nvasive coronary angiography (ICA). Potential study sub-
ects were screened and enrolled by a site research coordi-
ator if they met both inclusion and exclusion criteria. Study
ubjects were asked to undergo a research CCTA, as well as
ata and blood collection as specified by a pre-defined
esearch protocol.
Individuals were eligible for participation in the ACCU-
ACY trial if they were 18 years of age, experienced
ypical or atypical chest pain, and were being referred for
onemergent ICA.
Individuals were excluded from participation in the AC-
URACY trial for the following reasons: known allergy to
odinated contrast; baseline renal insufficiency (creatinine c1.7 mg/dl); irregular cardiac
hythm; resting heart rate 100
eats/min; resting systolic blood
ressure 100 mm Hg; contra-
ndication to beta-blocker,
alcium-channel blocker, or ni-
roglycerin; pregnancy; and
nown history of CAD (prior
yocardial infarction, percutane-
us transluminal coronary angio-
lasty or intracoronary stent, or
oronary artery bypass surgery).
mportantly, patients were not
xcluded for an elevated CAC
core or body mass index.
The study was performed at 16
enters in the U.S. (Online Ap-
endix). Before the study com-
enced, each Institutional Re-
iew Board had reviewed and
pproved the study protocol and
atient safety monitoring plan.
rotocols associated with patient
nrollment, safety analysis, image
cquisition, image interpretation, and statistical analysis
ere developed by a Steering Committee. GE Healthcare
Milwaukee, Wisconsin) performed study monitoring, data
anagement, and quality control. Adverse and serious
dverse events were determined for follow-up by a Data and
afety Monitoring Board.
ample size. Estimation of sample sizes using a binary end
oint for each subject (e.g., agreement between CCTA and
CA, whether sensitivity or specificity) gave a conservative
stimate of the required sample size. Based on historical
ata, we assumed values for sensitivity and specificity of 0.88
standard deviation: 0.045) at the patient level, which
equired a minimum of 173 subjects to reject the null
ypothesis that either sensitivity or specificity is 0.80 in
avor of the alternative 0.80.
CTA image acquisition. Study subjects underwent
CTA before conventional ICA. All CCTA scans were
erformed with a 64-multidetector row Lightspeed VCT
canner (GE Healthcare). All patients were in normal sinus
hythm at the time of the CCTA scan. Individuals present-
ng with baseline heart rates 65 beats/min were adminis-
ered oral beta-blocker therapy as the preferred method for
lowing down the heart rate. Intravenous administration
as allowed in the protocol, using metoprolol at 5 mg
ncrements to a total possible dose of 25 mg to achieve a
esting heart rate 65 beats/min. All patients eligible for
CTA were scanned, whether or not the goal of a heart rate
65 beats/min was achieved.
Following a scout radiograph of the chest (anteroposte-
ior and lateral), a timing bolus (using 10 to 20 ml contrast)
as performed to detect time to optimal contrast opacifi-
Abbreviations
and Acronyms
AUC  area under the
receiver-operating
characteristic curve
CAC  coronary artery
calcium
CAD  coronary artery
disease
CCTA  coronary
computed tomographic
angiography
ICA  invasive coronary
angiography
MDCT  multidetector
(row) computed
tomography
NPV  negative predictive
value
PPV  positive predictive
value
QCA  quantitative
coronary angiographyation in the axial image at a level immediately superior to
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The ACCURACY Trial of 64-MDCT November 18, 2008:1724–32he ostium of the left main artery. Nitroglycerine 0.4 mg
ublingually was administered immediately before contrast
njection. During CCTA acquisition, 80-ml iodinated con-
rast (Visipaque, GE Healthcare, Buckinghamshire, United
ingdom) was injected using a triple-phase contrast proto-
ol: 60-ml iodixanol, followed by 40 ml of a 50:50 mixture
f iodixanol and saline, followed by a 50-ml saline flush.
etrospective electrocardiogram-gated helical contrast-
nhanced CCTA was performed, with scan initiation 20
m above the level of the left main artery to 20 mm below
he inferior myocardial apex. The scan parameters were 64
0.625 mm collimation, tube voltage 120 mV, and
ffective mA 350 to 780 mA. Radiation reduction algo-
ithms using electrocardiography modulation were used,
hich reduce radiation exposure (mA) during systole and
nd-diastole. After scan completion, multiphasic recon-
truction of the CCTA scans was performed, with recon-
tructed images from 70% to 80% by 5% increments and 5%
o 95% by 10% increments.
CTA interpretation. The CCTA images were inter-
reted separately by 3 readers (M.J.B., D.D., and J.K.M.)
linded to all patient characteristics and ICA results. All
CTA images were evaluated on a 3-dimensional image
nalysis workstation (GE Advantage Workstation, GE
ealthcare, Milwaukee, Wisconsin). The CCTA readers
ere permitted to use any or all of the available post-
rocessing image reconstruction algorithms, including
-dimensional axial and 3-dimensional maximal intensity
rojection, multiplanar reformat, cross-sectional analysis,
nd volume-rendered technique.
Coronary arteries were scored using a 15-segment AHA
Figure 1 Computed Tomographic Angiogram and Invasive Angio
Demonstrating Significant Left Anterior Descending A
(A) Right anterior oblique orientation of left anterior descending artery with quantit
view (inset) of the left anterior descending artery demonstrating obstructive coron
artery demonstrating obstructive coronary artery stenosis. (D) Volume-rendered vie
present on the computed tomographic angiogram and corresponding invasive angioronary artery classification, as previously described (3). An cverall assessment of image quality and coronary supply dom-
nance was performed on the subject level (4,5). For each
oronary segment, readers assessed whether coronary segments
ere evaluable. For any coronary artery segments considered to
e nonevaluable, stenosis severity was assigned based on the
utcome of the most adjacent proximal and identifiable seg-
ent, as previously described (6). A semiquantitative scale was
sed by the CCTA readers to grade extent of luminal stenosis
s a percentage of the vessel diameter using visual estimations.
tenosis severity was recorded in the following manner: no
tenosis; 1% to 29% stenosis; 30% to 49% stenosis; 50% to 69%
tenosis; 70% to 99% stenosis; and 100% stenosis. For coronary
rtery segments considered to have 100% stenosis by CCTA,
ll segments distal to the occlusion were excluded from analysis
Fig. 1).
The degree of coronary artery stenosis identified by
CTA was assigned based upon a consensus of 2 of the
blinded CCTA readers who identified narrowing of the
oronary artery lumen at a threshold of 50% or 70% stenosis.
onsensus was achieved on a per-patient and per-vessel
evel. Consensus was obtained in all but 3 cases.
CA image acquisition and interpretation. Selective ICA
as performed by standard transfemoral arterial catheter-
zation. A minimum of 8 projections were obtained (mini-
um of 5 views for the left coronary artery system and
inimum of 3 views for the right coronary artery system).
ecause of differences in cardiac position, angles of projec-
ion for ICA differed slightly among study subjects.
All ICA images were interpreted by an independent ICA
eader (J.G.J.) blinded to all patient characteristics and
CTA results. The ICAs were quantitatively evaluated for
Disease
oronary angiography. (B) Multiplanar reformation and short-axis cross-sectional
ery stenosis. (C) Curved multiplanar reformat of the left anterior descending
he left anterior descending artery. Arrows indicate the significant stenosis
.gram
rtery
ative c
ary art
w of t
ogramoronary artery stenosis with quantitative coronary angiog-
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November 18, 2008:1724–32 The ACCURACY Trial of 64-MDCTaphy (QCA) software (CAAS, Pie Medical Imaging,
aastricht, the Netherlands). Any segment deemed visually
o have 15% stenosis was quantified. Coronary artery
egments by QCA were also evaluated using a 15-segment
HA coronary tree model and were judged as having
ignificant stenosis at 2 levels (i.e., if 50% or 70%
uminal narrowing of the coronary artery diameter was
resent).
ata analysis. In all analyses, all patients and all vessels
ere included. Analyses were performed separately for 2
istinct conditions—50% and 70% luminal diameter
arrowing—that defined obstructive coronary artery steno-
is. For the patient-based analysis, a true-positive was
efined as the presence of 1 coronary artery segment
onsidered to have an obstructive stenosis by both CCTA
nd ICA, irrespective of location. For the vessel-based
nalysis, a true-positive was defined as the presence of 1
oronary artery segment considered to have an obstructive
tenosis by both CCTA and ICA in a single arterial system.
our arterial systems were predefined and consisted of the:
) left main artery; 2) left anterior descending artery
nclusive of diagonal branches; 3) left circumflex artery
nclusive of obtuse marginal and left-sided posterolateral
ranches; and 4) right coronary artery inclusive of posterior
escending artery and right-sided posterolateral branches.
amus intermediate arteries were considered to be the first
btuse marginal branch for per-vessel analyses.
tatistical analysis. Categorical variables are presented as
requency and percentage, continuous variables as mean 
D. The area under the receiver operating characteristic
urve (AUC) was calculated for CCTA to identify obstruc-
ive coronary artery stenosis at either 50% or 70% threshold.
ll statistical analyses were performed using SAS Propri-
tary Software, version 9.1 (SAS Institute, Cary, North
arolina).
esults
atient characteristics. There were 245 subjects initially
nrolled into the study. Fifteen subjects did not complete
ither CCTA or ICA (withdrew after CCTA and did not
ndergo ICA or opted out of the CCTA and only under-
ent ICA) and were therefore excluded from the final
fficacy analyses. Of the patient study cohort, 147 patients
nderwent stress testing by a range of different tests,
ncluding exercise treadmill testing (n  17), exercise
chocardiogram stress testing (n  28), exercise nuclear
tress testing (n  96), pharmacological echocardiographic
tress testing (n  2), and pharmacological nuclear stress
esting (n  4). The remainder of the test cohort was
eferred on the basis of symptoms and/or testing not
erformed at the primary site.
One subject experienced a coronary artery dissection at
he time of ICA involving 2 coronary artery segments
proximal right coronary artery, mid-right coronary artery).
or this patient, efficacy analyses were performed based lpon a total of 13 rather than 15 coronary segments,
xcluding comparison of these 2 dissected segments from
he ICA and CCTA. Patient-level data were available for
fficacy analysis for 230 subjects (mean age: 57  10 years;
9.1% male) (Table 1). The mean inter-test interval be-
ween CCTA and ICA was 5.9  4.3 days.
atient-based evaluation. The CCTA test characteristics
nd performance for patient-based evaluation are listed in
able 2. There were 57 (24.8%) and 32 (13.9%) subjects
ound to have 50% or 70% stenosis, respectively, by
CA (Figs. 1 and 2). Discordance—specifically, the first
eader scoring a subject’s examination nonevaluable, a sec-
nd reader scoring an examination without obstructive
tenosis, and a third reader scoring an examination with
bstructive coronary stenosis— occurred for 3 subjects
1.3%), which were not included in the patient-level efficacy
nalysis. Among the 55 patients with 50% stenosis by
CA, 52 were correctly identified as having 50% stenosis
y CCTA. Among the 31 patients with 70% stenosis by
CA, 29 were correctly identified as having 70% stenosis
y CCTA. The AUC for identification of patients with
50% coronary artery stenosis by QCA was 0.96 (95% CI:
.94 to 0.98). Applying CCTA stenosis thresholds to
dentify 70% stenosis by QCA resulted in a similarly high
UC of 0.95 (95% CI: 0.92 to 0.97) (Fig. 3). Sensitivity at
oth the 50% and 70% thresholds of disease was 95% and
4%, respectively, specificity was 83%, and negative predic-
ive value (NPV) was 99% (Table 2). Given the low to
ntermediate prevalence of disease, positive predictive value
PPV) was low (64% and 48% for 50% and 70% thresholds
f disease, respectively). Adding in the 3 unevaluable (due to
aseline Demographics of Study Population
Table 1 Baseline Demographics of Study Population
Age (yrs) 57 10
Male gender 136 (59%)
Race
Caucasian 202 (87.8%)
African American 13 (5.7%)
Hispanic 8 (3.5%)
Other 7 (3.1%)
Height (cm) 172 11 (140–198)
Weight (kg) 93 21 (49–174)
Body mass index (kg/m2) 31.4 6.2 (16.8–50.5)
Heart rate (beats/min)* 60 12
Creatinine (mg/dl) 1.0 0.2
Agatston coronary artery calcium score 284 538
Diabetes 55 (23.9%)
Hypertension 154 (67.0%)
Hyperlipidemia 157 (68.3%)
Family history of coronary artery disease* 169 (73.5%)
Smoker 128 (55.7%)
Obesity 90 (39.1%)
Sedentary lifestyle 78 (33.9%)
alues are n (%) or mean  SD (95% confidence interval). *At the time of coronary computed
omographic angiography.ack of agreement) patients, the results remained statistically
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The ACCURACY Trial of 64-MDCT November 18, 2008:1724–32imilar (at 50% threshold: sensitivity 94.7%, specificity
2.1%, PPV 64.2%, and NPV 99.3%; at 70% threshold:
ensitivity 93.8%, specificity 81.8%, PPV 47.6%, and NPV
8.8%).
essel-based evaluation. The CCTA test characteristics
nd performance for vessel-based evaluation are listed in
able 3. For the vessel-based evaluation, 3 vessels were not
valuable by QCA and 7 vessels were scored discordantly by
CTA readers, resulting in 910 vessels in 229 patients. In
otal, 89 (9.7%) and 39 (4.3%) vessels reached the 50% or
0% stenosis threshold, respectively, by QCA. Among the
9 vessels with 50% stenosis by QCA, 73 vessels were
orrectly identified as having 50% stenosis by CCTA.
mong the 39 vessels with 70% stenosis by QCA, 32
ere correctly identified as having 70% stenosis by
Patient-Based Analysis
Table 2 Patient-Based Analysis
Estimate, % 95%
50% stenosis
Sensitivity 95 85
Specificity 83 76
PPV 64 53
NPV 99 96
70% stenosis
Sensitivity 94 79
Specificity 83 77
PPV 48 35
NPV 99 96
CCTA  coronary computed tomographic angiography; CI  confidenc
Figure 2 Computed Tomographic Angiogram Demonstrating Ob
Disease of the Left Circumflex Artery With Quantitativ
(A) Right anterior oblique orientation of the left circumflex artery with quantitative
view (inset) of the left circumflex artery demonstrating obstructive coronary artery
left circumflex artery demonstrating obstructive coronary artery stenosis. Arrows in
sponding invasive angiogram.CTA. For both 50% and 70% stenosis thresholds, sensi-
ivity was 84%, specificity was 90% and 92%, respectively,
nd NPV was 99% (Table 3).
alcium score. We examined diagnostic performance of
CTA based on baseline CAC score, stratified by 400
ersus 400 Agatston units. Stratifying the diagnostic test
erformance characteristics of CCTA by these CAC score
hresholds resulted in no change in diagnostic sensitivity but
reduction in specificity. The patient-based sensitivity for
he presence of 50% stenosis for patients with calcium
cores 400 versus 400 or 600 versus 600 Agatston
nits was 95.8% versus 93.6% (p  0.71) and 96.9% versus
1.3% (p  0.37), respectively. The specificity of CCTA-
iagnosed obstructive disease at the 50% stenosis threshold
as reduced in patients with coronary artery calcium scores
Subjects in
Group, n
Subjects Correct
by CCTA, n
55 52
172 142
81 52
143 142
31 29
196 162
60 29
164 162
al; NPV  negative predictive value; PPV  positive predictive value.
tive
giography Correlation
ry angiography. (B) Curved multiplanar reformation and short-axis cross-sectional
is. (C) Multiplanar reformation and short-axis cross-sectional view (inset) of the
significant stenosis present on the computed tomographic angiogram and corre-CI, %
–99
–88
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–100struc
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November 18, 2008:1724–32 The ACCURACY Trial of 64-MDCT400 versus 400 Agatston units (86.3% vs. 52.6%; p 
.0003).
ody mass index and heart rate. Diagnostic perfor-
ance of CCTA was examined in nonobese versus obese
tudy participants, stratified by body mass index 30
g/m2 or 30 kg/m2. For CCTA detection of 50%
oronary artery stenosis at the patient level in nonobese
ersus obese subjects, sensitivity was 94.4% and 94.7%
p  0.96), respectively, and specificity was 76.4% and
7.0% for 30 kg/m2 or 30 kg/m2, respectively
p  0.07).
Diagnostic performance of CCTA for detection of
50% coronary artery stenosis at the patient level did not
iffer in individuals with heart rates 65 beats/min
ersus 65 beats/min, with a diagnostic sensitivity of
2.9% versus 100%, respectively, and a diagnostic speci-
city of 82.3% versus 82.8%, respectively (p  0.35 for
oth comparisons).
Figure 3 ROC Curve Evaluating Diagnostic Accuracy of CCTA C
Receiver-operating characteristic (ROC) curve for identification of patients by coron
quantitative coronary angiography. The points on the plot represent the 6 categori
stenosis; 2  50% to 69% stenosis; 3  30% to 49% stenosis; 4  30% steno
ease/no disease of 70% stenosis by invasive angiography. AUC  area under the
Vessel-Based Analysis
Table 3 Vessel-Based Analysis
Estimate, % 95%
50% stenosis
Sensitivity 84 74
Specificity 90 88
PPV 51 43
NPV 99 98
70% stenosis
Sensitivity 84 69
Specificity 92 90
PPV 36 26
NPV 99 98Abbreviations as in Table 2.iscussion
hese results of the ACCURACY trial represent the first
rospective blinded multicenter study evaluating the diag-
ostic performance of 64-multidetector row CCTA com-
ared with QCA in chest pain subjects without known
AD being clinically referred for nonemergent ICA. The
resent data demonstrate high diagnostic performance of
4-multidetector row CCTA for detection of obstructive
oronary artery stenosis at both 50% and 70% stenosis
hresholds. Of equal importance, the 99% NPV of CCTA
t the patient and vessel levels establishes it as a highly
ffective noninvasive alternative to ICA for the exclusion of
bstructive coronary artery stenosis. The specificity of CAD
bstruction detection in this study was 83% (at both 50%
nd 70% stenosis thresholds). This specificity is on par with
ther noninvasive imaging modalities (e.g., stress echocar-
iogram, stress nuclear), whereas the diagnostic sensitivity
nd NPV are higher (7). These results are in keeping with
ared With Invasive Angiogram
mputed tomographic angiography (CCTA) with 70% coronary artery stenosis by
nterpretation for CCTA used in this study: 0  100% stenosis; 1  70% to 99%
d 5  no stenosis. The ROC shows us the degree to which we predict dis-
er-operating characteristic curve; CI  confidence interval.
Vessels in
Group, n
Vessels Corrected
by CCTA, n
87 73
823 744
143 73
754 744
38 32
872 801
90 32
807 801omp
ary co
es of i
sis; an
receivCI, %
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–59
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The ACCURACY Trial of 64-MDCT November 18, 2008:1724–32arlier single-center studies in which CCTA demonstrated
igher diagnostic performance for obstructive coronary
rtery stenosis detection compared with myocardial perfu-
ion imaging (8,9).
To date, only one other multicenter trial, using former-
eneration 16-multidetector row CCTA, has been reported
valuating CCTA accuracy (10). In that study, the diagnos-
ic performance of 16-multidetector row CCTA was infe-
ior to that which had been previously reported in single-
enter studies, primarily due to high rates of false positivity
nd coronary artery segment nonevaluability. That study
sed a cutoff of50% stenosis in a major epicardial vessel to
efine significant CAD.
In contrast, the present study used newer-generation
4-multidetector row CCTA for evaluation of CCTA
iagnostic performance. Compared with 16-row CCTA,
4-MDCT studies represent a significant improvement in
iagnostic accuracy and evaluable segments. New-
eneration 64-MDCT systems permit the acquisition of
ardiac studies in 10 s, allowing faster contrast injection
ates and lower contrast volume requirements, and reducing
he number of artifacts related to inadequate breath-holding
nd heart rate variability. An earlier meta-analysis of indi-
idual 64-MDCT studies demonstrated a sensitivity of 96%
nd specificity of 73% (1). The present multicenter study
ith blinded readers for both CTA (3 readers) and invasive
ngiography (QCA), demonstrates very similar numbers,
ith higher per-patient specificity. In addition, the present
tudy evaluated CCTA diagnostic accuracy at QCA stenosis
t 2 thresholds: 50% stenosis, similar to that which has
een studied in earlier CCTA studies; and 70%, in
eeping with “real-world” practice in which a 70% steno-
is may be a more useful clinical discriminator for obstruc-
ive CAD. Use of both thresholds for significant stenosis
esulted in nearly identical results, affirming the utility of
CTA to identify disease at both the 50% and 70% stenosis
hresholds. The receiver-operating characteristic curve in
igure 3 shows the degree to which we predict disease/no
isease of 70% stenosis by invasive angiography. Because
CTA tends to overpredict stenosis, all stenoses of 70%
n invasive angiography were identified at the 50%
ut-point for CCTA.
Although PPV and NPV are generally well-accepted
easures of diagnostic test performance, their values may be
ffected by disease prevalence within specific study popula-
ions. In contrast, likelihood ratios are measures of diagnos-
ic test characteristics that simultaneously incorporate sen-
itivity and specificity, and are considered to be generally
naffected by the prevalence of disease. In the present study,
he positive and negative likelihood ratios were 5.56 and
.06, respectively, at the 50% threshold and 5.53 and 0.07,
espectively, at the 70% threshold, indicating the high
agnitude of power of CCTA to substantially alter pre-test
robabilities, particularly for negative CCTAs. The calcu-
ated odds ratios of CCTA within the present study cohort
ere high (92.7 and 79.0 at the 50% and 70% thresholds, pespectively) and further demonstrate the strong ability of a
ositive CCTA to identify subjects with obstructive coro-
ary artery stenosis compared with those with a negative
CTA.
Due to the limited temporal resolution of MDCT scan-
ers, significant coronary artery motion that occurs at higher
eart rates or during irregular heart rhythms may render
ertain coronary artery segments difficult to evaluate. Earlier
tudies have generally excluded these nonevaluable coronary
rtery segments from final accuracy analyses (1,11,12).
lthough the number of coronary artery segments con-
idered nonevaluable has decreased with use of 64-
ultidetector row CCTA compared with older-generation
DCT scanners, critics have contended that exclusion of
onevaluable segments falsely elevates the diagnostic per-
ormance of CCTA (2). In the present study, overall CCTA
iagnostic performance was based upon the totality of all
oronary artery segments, with no segments being excluded
rom analysis due to nonevaluability. The CCTA readers
erformed systematic evaluation of scans in multiple cardiac
hases and used an assortment of 3-dimensional post-
rocessing algorithms (maximal intensity projection, multi-
lanar reformat, volume-rendered technique, cross-section)
or optimal visualization of coronary arteries, thereby im-
roving the likelihood of segment evaluability. The data
emonstrated that inclusion of all coronary segments for
fficacy analyses of CCTA scans performed in a careful
anner results in excellent diagnostic accuracy.
In the previously reported 16-row CCTA multicenter
rial, as well as numerous single-center studies using 16- and
4-row CCTA, study subjects were routinely excluded
ased on baseline elevated CAC scores. Historically, CCTA
iagnostic accuracy has been adversely affected by inclusion
f individuals with high CAC scores, and many earlier
tudies simply elected to exclude them (1,11,12). Impor-
antly, no subject in the present study was excluded for
aseline CAC, and overall diagnostic performance remained
igh.
Given the limited spatial resolution of MDCT scanners,
he diagnostic accuracy of CCTA has been commonly
eported in the context of vessels of diameters1.5 or2.0
m. Inclusion of smaller vessels of 2 mm diameter has
enerally unfavorably affected CCTA performance, and
arlier studies have simply elected to ignore them (1,11,12).
he high diagnostic accuracy of 64-multidetector row
CTA in the present analysis included all vessels, irrespec-
ive of size, for final efficacy analyses.
The average body mass index of our study population
as 31.4  6.2 kg/m2, indicating a generally obese
opulation (13). Because earlier investigations have re-
orted decreased accuracy for CCTA in obese individu-
ls, the present results indicate that proper use of current-
eneration 64-multidetector row scanners in obese subjects
an still yield highly accurate results (12).
Earlier studies evaluating CCTA accuracy have been
erformed primarily in academic centers with expertise in
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hether the results thus far reported represent performance
eneralizable to other academic or nonacademic centers has
o date been unknown. The present study enrolled subjects
rom predominantly nonacademic (private) centers: 83% of
he subjects were recruited by nonacademic centers versus
nly 17% from academic centers. Therefore, with adequate
raining, any imaging center can perform CCTA procedures
ith high quality. Interpretation of CCTAs was performed
y 2 readers from academic centers and 1 reader from a
onacademic center. Despite the diversity in enrolling
enters and CCTA interpreters, diagnostic performance of
4-multidetector row CCTA remained high, thus establish-
ng it as a highly effective diagnostic modality in a variety of
ettings.
Importantly, 1 iatrogenic coronary artery dissection oc-
urred in a study subject undergoing ICA. Although the risk
f adverse events for ICA is generally considered to be low,
ignificant and potentially life-threatening complications
an arise, including not only coronary artery dissection, but
lso arrhythmia, stroke, hemorrhage, myocardial infarction,
nd death (14). This single event during the ICA procedure
n the present study confirms the low incidence of such
omplications, while at the same time highlighting the
nhanced risk of potential complications of ICA compared
ith a noninvasive alternative.
Subjects within the present study possessed a prevalence
f obstructive coronary artery stenosis at the 50% thresh-
ld of only 25%, despite clinical indications for nonemer-
ent ICA, uniformity of chest pain, and high prevalence of
stablished cardiac risk factors. This intermediate preva-
ence of obstructive coronary artery stenosis, identified by
CTA and confirmed by ICA, underscores the common
cenario in which patients with clinical indications for ICA
ail to have clinically significant anatomic disease (15).
Recently published appropriateness criteria addressing
he clinical use of CCTA have suggested that its greatest
otential utility may be for the intermediate-risk patient
ith chest pain syndrome or acute chest pain (16). Similarly,
he AHA scientific statement on CT angiography states,
CT coronary angiography is reasonable for the assessment
f obstructive disease in symptomatic patients (Class IIa)”
7). Considering these recommendations, it should be noted
hat most of the earlier studies evaluating the diagnostic
ccuracy of CCTA were performed with patients with a
enerally high prevalence of obstructive coronary artery
tenosis. Because disease prevalence may directly impact the
haracteristics and performance of a diagnostic test, CCTA
equires efficacy assessment in patient populations with
ntermediate disease prevalence if it is to be successfully used
n this population. The prevalence of obstructive coronary
rtery stenosis at the 50% threshold in the present study was
nly 24.8%, a prevalence that is less than half of that which
ad been reported in earlier pooled analyses (11). The
resent data expand the current base of CCTA diagnostic
ccuracy beyond high disease prevalence populations to wymptomatic subjects with intermediate disease prevalence,
nd affirm CCTA’s potential diagnostic efficacy in
ntermediate-risk patients with chest pain syndrome or
cute chest pain. The results demonstrate that in symptom-
tic patients, a negative (including nonobstructive disease)
CTA can noninvasively exclude angiographic disease,
ith post-test probabilities for patient- or vessel-specific
isease approaching 1%. For example, a 57-year-old man
ith a pre-test probability of 25% and no obstructive disease
n CT angiography has a post-test probability of 0.9%.
tudy limitations. We enrolled subjects in outpatient set-
ings without known CAD who were being referred for
onemergent conventional coronary angiography. There-
ore, whether these results can be extrapolated to individuals
ith known CAD or to other settings (e.g., emergency
epartment) requires further study. Furthermore, only 1
linded reader interpreted the ICAs. Nevertheless, the
eference standard used in the present study was QCA
ather than semiquantitative assessment of luminal diameter
tenosis by ICA, a technique more prone to interobserver
ariability (17,18). We elected to implement tube current
odulation to reduce radiation dose. Tube current modu-
ation, however, limits the ability to interpret the coronary
natomy in cardiac phases other than the modulated phase
nd may result in artifacts in patients with irregular heart
ates. Finally, no interpreting format was pre-specified for
he CCTA readers, who used a variety of interpretative
-dimensional post-processing algorithms, which precludes
efinitive comparison of 1 CCTA interpretation technique
o another (19).
The benefit of this study is that it is a multicenter
nvestigation using established methods widely used by
ractitioners and under less than ideal conditions (variable
eart rates, obesity, high CAC scores, and dose modulation)
hat mimic current clinical practice. Despite these limita-
ions, the performance of 64-MDCT was quite good. The
nalysis methods focused on the diagnostic accuracy of
etermining obstructive disease, not on establishing the
alue in defining atherosclerotic plaque burden. CCTA is
learly not as accurate as angiography in finding obstructive
AD (the findings of multiple studies put the PPV at
60%). However, this study, as well as earlier single-center
valuations, demonstrate that CCTA provides a valuable
PV as well as a nearly 100% PPV for presence of
therosclerotic plaque. The high NPV for obstructive dis-
ase and the high PPV for atherosclerotic plaque makes
CTA unique in evaluating patients in which the suspicion
or “obstructive” is intermediate.
onclusions
he present results of the ACCURACY trial provide the
rst prospective multicenter data evaluating the diagnostic
erformance of current-generation 64-multidetector row
CTA compared with QCA in symptomatic individuals
ithout known CAD with intermediate disease prevalence.
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The ACCURACY Trial of 64-MDCT November 18, 2008:1724–32CTA demonstrates high accuracy for detection of ob-
tructive coronary artery stenosis. Importantly, the high
PV (99%) firmly establishes CCTA as an effective non-
nvasive method to rule out obstructive coronary artery
tenosis.
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